vs
Nano Dimension Ltd.（NNDM）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
Vericel Corp的季度营收约是Nano Dimension Ltd.的1.6倍（$92.9M vs $57.8M），Vericel Corp净利率更高（25.0% vs -171.1%，领先196.1%），Vericel Corp自由现金流更多（$12.8M vs $-21.1M）
Nano Dimension Ltd.是知名增材制造电子解决方案供应商，主营高精度3D打印机、配套耗材及相关软件，可生产印刷电路板、微电子元件等器件，服务航空航天、国防、医疗、汽车、工业电子等领域的全球客户。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
NNDM vs VCEL — 直观对比
营收规模更大
VCEL
是对方的1.6倍
$57.8M
净利率更高
VCEL
高出196.1%
-171.1%
自由现金流更多
VCEL
多$33.9M
$-21.1M
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.8M | $92.9M |
| 净利润 | $-98.8M | $23.2M |
| 毛利率 | 43.1% | 78.7% |
| 营业利润率 | -155.1% | 24.1% |
| 净利率 | -171.1% | 25.0% |
| 营收同比 | — | 23.3% |
| 净利润同比 | — | 17.3% |
| 每股收益（稀释后） | $-0.45 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NNDMVCEL
| Q4 25 | — | $92.9M | ||
| Q3 25 | — | $67.5M | ||
| Q2 25 | — | $63.2M | ||
| Q1 25 | — | $52.6M | ||
| Q4 24 | $57.8M | $75.4M | ||
| Q3 24 | — | $57.9M | ||
| Q2 24 | $28.4M | $52.7M | ||
| Q1 24 | — | $51.3M |
净利润NNDMVCEL
| Q4 25 | — | $23.2M | ||
| Q3 25 | — | $5.1M | ||
| Q2 25 | — | $-553.0K | ||
| Q1 25 | — | $-11.2M | ||
| Q4 24 | $-98.8M | $19.8M | ||
| Q3 24 | — | $-901.0K | ||
| Q2 24 | $-79.2M | $-4.7M | ||
| Q1 24 | — | $-3.9M |
毛利率NNDMVCEL
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | 43.1% | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | 45.8% | 69.5% | ||
| Q1 24 | — | 68.9% |
营业利润率NNDMVCEL
| Q4 25 | — | 24.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -24.3% | ||
| Q4 24 | -155.1% | 24.5% | ||
| Q3 24 | — | -4.3% | ||
| Q2 24 | — | -11.5% | ||
| Q1 24 | — | -10.7% |
净利率NNDMVCEL
| Q4 25 | — | 25.0% | ||
| Q3 25 | — | 7.5% | ||
| Q2 25 | — | -0.9% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | -171.1% | 26.3% | ||
| Q3 24 | — | -1.6% | ||
| Q2 24 | -279.4% | -8.9% | ||
| Q1 24 | — | -7.5% |
每股收益（稀释后）NNDMVCEL
| Q4 25 | — | $0.46 | ||
| Q3 25 | — | $0.10 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | $-0.45 | $0.40 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | $-0.35 | $-0.10 | ||
| Q1 24 | — | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $317.2M | $137.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $860.0M | $354.6M |
| 总资产 | $902.5M | $488.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NNDMVCEL
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | $317.2M | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | $231.8M | $102.5M | ||
| Q1 24 | — | $110.6M |
股东权益NNDMVCEL
| Q4 25 | — | $354.6M | ||
| Q3 25 | — | $321.9M | ||
| Q2 25 | — | $306.8M | ||
| Q1 25 | — | $295.5M | ||
| Q4 24 | $860.0M | $292.0M | ||
| Q3 24 | — | $257.5M | ||
| Q2 24 | $870.3M | $243.0M | ||
| Q1 24 | — | $233.9M |
总资产NNDMVCEL
| Q4 25 | — | $488.0M | ||
| Q3 25 | — | $453.3M | ||
| Q2 25 | — | $435.6M | ||
| Q1 25 | — | $424.6M | ||
| Q4 24 | $902.5M | $432.7M | ||
| Q3 24 | — | $390.4M | ||
| Q2 24 | $911.0M | $376.8M | ||
| Q1 24 | — | $356.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.9M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | $-21.1M | $12.8M |
| 自由现金流率自由现金流/营收 | -36.5% | 13.8% |
| 资本支出强度资本支出/营收 | 3.8% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | — | $24.7M |
8季度趋势，按日历期对齐
经营现金流NNDMVCEL
| Q4 25 | — | $15.0M | ||
| Q3 25 | — | $22.1M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | — | $6.6M | ||
| Q4 24 | $-18.9M | $22.2M | ||
| Q3 24 | — | $10.2M | ||
| Q2 24 | $-30.7M | $18.5M | ||
| Q1 24 | — | $7.2M |
自由现金流NNDMVCEL
| Q4 25 | — | $12.8M | ||
| Q3 25 | — | $19.5M | ||
| Q2 25 | — | $81.0K | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | $-21.1M | $8.5M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $-6.8M |
自由现金流率NNDMVCEL
| Q4 25 | — | 13.8% | ||
| Q3 25 | — | 28.8% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | -36.5% | 11.2% | ||
| Q3 24 | — | -15.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -13.3% |
资本支出强度NNDMVCEL
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | 3.8% | 18.3% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.3% |
现金转化率NNDMVCEL
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NNDM
暂无分部数据
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
